CN Patent

CN107400082A — 一种取代哌啶衍生物的制备方法

Assigned to Hunan Huateng Pharmaceutical Co Ltd · Expires 2017-11-28 · 8y expired

What this patent protects

本发明公开了一种取代哌啶衍生物4‑((2‑(氨基甲基)‑6‑甲基苯氧基)甲基)哌啶‑1‑羧酸叔丁酯的制备方法，以2‑羟基‑3‑甲基苯甲醛为起始原料，经过肟化、消除、醚化、催化加氢反应得到目标产物，该化合物是重要的医药中间体。

USPTO Abstract

本发明公开了一种取代哌啶衍生物4‑((2‑(氨基甲基)‑6‑甲基苯氧基)甲基)哌啶‑1‑羧酸叔丁酯的制备方法，以2‑羟基‑3‑甲基苯甲醛为起始原料，经过肟化、消除、醚化、催化加氢反应得到目标产物，该化合物是重要的医药中间体。

Drugs covered by this patent

Patent Metadata

Patent number
CN107400082A
Jurisdiction
CN
Classification
—
Expires
2017-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Hunan Huateng Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.